Flavoxanthin (Tagetes erecta extract)

Flavoxanthin is a xanthophyll carotenoid derived from Tagetes erecta (marigold) that exhibits antioxidant properties through free radical scavenging activity. This compound may support eye health by potentially protecting retinal tissues from oxidative damage, though clinical evidence remains limited.

Origin & History

Flavoxanthin is a xanthophyll carotenoid found in extracts of Tagetes erecta L. (marigold) flowers, a plant native to Mexico but commercially cultivated in regions like Pakistan. It is extracted from marigold petals using solvents such as 80% ethanol, acetone, or hexane via conventional solvent extraction or ultrasound-assisted methods, followed by purification steps including saponification.

Historical & Cultural Context

No historical or traditional medicinal uses of Flavoxanthin specifically are documented in the research. Tagetes erecta flowers are noted for commercial cultivation and potential as a source of bioactive compounds, but without reference to traditional medicine systems.

Health Benefits

• Antioxidant activity demonstrated through in vitro radical scavenging assays (DPPH, ABTS, FRAP) - evidence quality: preliminary (in vitro only)
• Potential eye health support as a xanthophyll carotenoid similar to lutein and zeaxanthin - evidence quality: theoretical (no clinical studies)
• May contribute to oxidative stress reduction via phenolic and flavonoid content - evidence quality: preliminary (in vitro only)
• Possible support for cellular protection through free radical neutralization - evidence quality: preliminary (in vitro only)
• Potential anti-inflammatory properties based on flavonoid profile - evidence quality: theoretical (no direct studies)

How It Works

Flavoxanthin exerts antioxidant effects by neutralizing free radicals through DPPH, ABTS, and FRAP pathways, similar to other xanthophyll carotenoids. As a carotenoid, it may accumulate in retinal tissues where it could filter harmful blue light and protect against lipid peroxidation. The compound's hydroxylated structure allows it to interact with cell membranes and scavenge reactive oxygen species.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specifically on Flavoxanthin from Tagetes erecta extract were found in the research. Current evidence is limited to phytochemical profiling and in vitro antioxidant assays showing correlations between phenolic/flavonoid content and radical scavenging activity.

Clinical Summary

Current evidence for flavoxanthin is limited to in vitro studies demonstrating antioxidant activity through radical scavenging assays. No human clinical trials have specifically evaluated flavoxanthin's effects on eye health or other conditions. The theoretical eye health benefits are based on its structural similarity to lutein and zeaxanthin, which have established clinical evidence. Additional research including animal studies and human trials is needed to validate potential health benefits.

Nutritional Profile

Flavoxanthin is a xanthophyll carotenoid (epoxy-carotenoid, C40H56O3, MW ~584.87) extracted from Tagetes erecta (marigold) flower petals. It is typically a minor carotenoid constituent within the marigold oleoresin extract, with the dominant carotenoids being lutein (80–90% of total carotenoids) and zeaxanthin (5–15%). Flavoxanthin itself generally constitutes <2–5% of total carotenoid content in crude marigold extracts, though concentrations vary significantly by cultivar, extraction method, and purification. Key bioactive compounds in Tagetes erecta extract alongside flavoxanthin include: lutein (typically 5–20 mg/g of oleoresin), zeaxanthin (0.5–3 mg/g), beta-carotene (trace to 0.5 mg/g), violaxanthin and neoxanthin (trace epoxy-carotenoids), phenolic acids (chlorogenic acid, gallic acid; approximately 2–8 mg GAE/g dry extract), and flavonoids (patuletin, quercetagetin, quercetin glycosides; approximately 1–5 mg QE/g dry extract). The extract also contains essential oils (tagetone, limonene, ocimene) in small quantities. Macronutrient content is negligible as the extract is used in very small doses (typically 5–20 mg carotenoid equivalents). Mineral content is minimal and not nutritionally significant. No meaningful fiber or protein content. Bioavailability notes: As an epoxy-carotenoid, flavoxanthin has lower bioavailability compared to non-epoxy xanthophylls like lutein; epoxy-carotenoids are susceptible to degradation in the acidic gastric environment and may undergo rearrangement to 5,8-furanoid (mutatochrome-type) derivatives, reducing absorption efficiency. Co-ingestion with dietary fat (5–10 g) substantially enhances carotenoid absorption. Esterified forms (flavoxanthin esters present in unprocessed oleoresin) require enzymatic hydrolysis by pancreatic lipase/cholesterol esterase before intestinal uptake; saponified (free) forms may show modestly improved absorption kinetics. Estimated oral bioavailability for epoxy-xanthophylls is roughly 30–50% that of lutein, which itself has approximately 10–20% bioavailability from supplements.

Preparation & Dosage

No clinically studied dosage ranges are available for Flavoxanthin (Tagetes erecta extract) as no human trials have been conducted. Extraction yields vary by method, with ultrasound-assisted acetone extracts yielding up to 1.76 mg/g lutein and 2.14 mg/g zeaxanthin, but standardization for clinical use is not established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lutein, Zeaxanthin, Quercetin, Vitamin E, Bilberry Extract

Safety & Interactions

Safety data for flavoxanthin supplementation is limited due to lack of clinical studies. As a carotenoid similar to lutein and zeaxanthin, it is likely well-tolerated at typical supplement doses. Potential interactions with fat-soluble vitamin absorption may occur, though specific drug interactions have not been documented. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data.